Development of a Clinical MALDI-ToF Mass Spectrometry Assay for SARS-CoV-2: Rational Design and Multi-Disciplinary Team Work. (2020)
Attributed to:
One Health and accelerating Vaccines for Ebola and Lassa (OVEL)
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.62176
Publication URI: https://www.repository.cam.ac.uk/handle/1810/315069
Type: Journal Article/Review